Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Vaishampayan, Ulka N"'
Autor:
Martinez Chanza N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Werner L; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Plimack E; Fox Chase Cancer Center, Philadelphia, PA, USA., Yu EY; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Alva AS; University of Michigan, Ann Arbor, MI, USA., Crabb SJ; University of Southampton, Southampton, UK., Powles T; Barts Cancer Institute, London, UK., Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Baniel J; Rabin Medical Center, Petah Tivka, Israel., Vaishampayan UN; Karmanos Cancer Institute, Detroit, MI, USA., Berthold DR; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Ladoire S; Georges François Leclerc Cancer Center, Dijon, France., Hussain SA; Clatterbridge Cancer Centre, Liverpool, UK., Milowsky MI; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Agarwal N; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA., Necchi A; Istituto Nazionale Tumori of Milan, Milano, MI, Italy., Pal SK; City of Hope, Duarte, CA, USA., Sternberg CN; San Camillo-Forlanini Hospital, Rome, Italy., Bellmunt J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Galsky MD; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Harshman LC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: LaurenC_Harshman@dfci.harvard.edu.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2020 Oct; Vol. 3 (5), pp. 671-679. Date of Electronic Publication: 2019 Jan 31.
Autor:
Sonpavde GP; Dana-Farber Cancer Institute, Boston, Massachusetts., Mariani L; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lo Vullo S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Raggi D; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Giannatempo P; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bamias A; University of Athens, Athens, Greece., Crabb SJ; University of Southampton, Southampton., Bellmunt J; Hospital del Mar Medical Research Institute, Barcelona, Spain., Yu EY; University of Washington, Seattle, Washington., Niegisch G; Department of Urology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany., Vaishampayan UN; Karmanos Cancer Center, Wayne State University, Detroit, Michigan., Theodore C; Hospital Foch, Suresnes, France., Berthold DR; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Srinivas S; Stanford University, Stanford, California., Sridhar SS; Princess Margaret Hospital Cancer Center, Toronto, Ontario, Canada., Plimack ER; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, New York., Powles T; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Galsky MD; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York., Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: andrea.necchi@istitutotumori.mi.it.
Publikováno v:
The Journal of urology [J Urol] 2018 Dec; Vol. 200 (6), pp. 1207-1214. Date of Electronic Publication: 2018 Sep 04.
Autor:
Agarwal N; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Pal SK; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California., Hahn AW; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Nussenzveig RH; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Pond GR; Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Gupta SV; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Wang J; Genitourinary Oncology Section, University of Arizona Cancer Center at Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, Arizona., Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia., Naik G; Department of Oncology, University of Alabama at Birmingham, Birmingham, Alabama., Ghatalia P; Department of Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Hoimes CJ; Division of Hematology/Oncology, Case Western Reserve University, Seidman Cancer Center, Cleveland, Ohio., Gopalakrishnan D; Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio., Barata PC; Division of Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington., Drakaki A; Department of Hematology/Oncology, University of California at Los Angeles Medical Center, Los Angeles, California., Faltas BM; Department of Medical Oncology, Weill-Cornell Medical College, New York City, New York., Kiedrowski LA; Guardant Health Inc, Redwood, California., Lanman RB; Guardant Health Inc, Redwood, California., Nagy RJ; Guardant Health Inc, Redwood, California., Vogelzang NJ; Department of Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada., Boucher KM; Division of Biostatistics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Vaishampayan UN; Department of Oncology, Karmanos Cancer Institute, Detroit, Michigan., Sonpavde G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Grivas P; Division of Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Publikováno v:
Cancer [Cancer] 2018 May 15; Vol. 124 (10), pp. 2115-2124. Date of Electronic Publication: 2018 Mar 08.
Autor:
Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: andrea.necchi@istitutotumori.mi.it., Sonpavde G; UAB Comprehensive Cancer Center, Birmingham, AL, USA., Lo Vullo S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Giardiello D; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Bamias A; University of Athens, Athens, Greece., Crabb SJ; University of Southampton, Southampton, UK., Harshman LC; Dana-Farber Cancer Institute, Boston, MA, USA., Bellmunt J; Dana-Farber Cancer Institute, Boston, MA, USA., De Giorgi U; IRCCS Istituto Scientifico Romagnolo per lo studio e la Cura dei Tumori, Meldola, Italy., Sternberg CN; San Camillo Forlanini Hospital, Rome, Italy., Cerbone L; San Camillo Forlanini Hospital, Rome, Italy., Ladoire S; Center Georges-François Leclerc, Dijon, France., Wong YN; Fox Chase Cancer Center, Philadelphia, PA, USA., Yu EY; University of Washington, Seattle, WA, USA., Chowdhury S; Guy's and St. Thomas' Hospital, London, UK., Niegisch G; Heinrich-Heine-University, Medical Faculty, Department of Urology, Düsseldorf, Germany., Srinivas S; Stanford University School of Medicine, Stanford, CA, USA., Vaishampayan UN; Karmanos Cancer Institute, Detroit, MI, USA., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Agarwal N; University of Utah, Salt Lake City, UT, USA., Alva A; University of Michigan, Ann Arbor, MI, USA., Baniel J; Rabin Medical Center, Petach Tikva, Israel., Golshayan AR; Medical University of South Carolina, Charleston, SC, USA., Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain., Bowles DW; Denver Veterans Affairs Medical Center, Eastern Colorado Health Care System, Denver, CO, USA., Milowsky MI; University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, NC, USA., Theodore C; Hopital Foch, Suresnes, France., Berthold DR; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Daugaard G; Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Sridhar SS; Princess Margaret Hospital, University Health Network, Toronto, Canada., Powles T; Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK., Rosenberg JE; Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Galsky MD; Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY, USA., Mariani L; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Publikováno v:
European urology [Eur Urol] 2017 Feb; Vol. 71 (2), pp. 281-289. Date of Electronic Publication: 2016 Oct 08.
Autor:
Balar AV; Genitourinary Cancers Program, Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA. Electronic address: arjun.balar@nyumc.org., Galsky MD; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Rosenberg JE; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Powles T; Barts Cancer Institute ECMC, Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK., Petrylak DP; Smilow Cancer Center, Yale University, New Haven, CT, USA., Bellmunt J; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Loriot Y; Département de médecine oncologique, Université Paris-Saclay and Gustave Roussy, Villejuif, France., Necchi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Hoffman-Censits J; Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA., Perez-Gracia JL; Department of Oncology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Navarre, Spain., Dawson NA; Medstar Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, USA., van der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Dreicer R; Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA., Srinivas S; Division of Oncology/Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Retz MM; Department of Urology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Joseph RW; Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA., Drakaki A; Department of Medicine, Division of Hematology and Oncology and Institute of Urologic Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Vaishampayan UN; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Sridhar SS; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada., Quinn DI; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Durán I; Department of Medical Oncology, Hospital Universitario Virgen del Rocío and Institute of Biomedicine of Seville, Seville, Spain., Shaffer DR; New York Oncology Hematology, Albany, NY, USA., Eigl BJ; British Columbia Cancer Agency, British Columbia, Vancouver, Canada., Grivas PD; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Yu EY; Division of Oncology, Department of Medicine, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Li S; Genentech, South San Francisco, CA, USA., Kadel EE 3rd; Genentech, South San Francisco, CA, USA., Boyd Z; Genentech, South San Francisco, CA, USA., Bourgon R; Genentech, South San Francisco, CA, USA., Hegde PS; Genentech, South San Francisco, CA, USA., Mariathasan S; Genentech, South San Francisco, CA, USA., Thåström A; Genentech, South San Francisco, CA, USA., Abidoye OO; Genentech, South San Francisco, CA, USA., Fine GD; Genentech, South San Francisco, CA, USA., Bajorin DF; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2017 Jan 07; Vol. 389 (10064), pp. 67-76. Date of Electronic Publication: 2016 Dec 08.
Autor:
Locke JA; University of British Columbia, Vancouver, BC, Canada., Pond GR; McMaster University, Hamilton, ON, Canada., Sonpavde G; UAB Comprehensive Cancer Center, Birmingham, AL., Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Giannatempo P; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Paluri RK; UAB Comprehensive Cancer Center, Birmingham, AL., Niegisch G; Heinrich Heine University, Medical Faculty, Dusseldorf, Germany., Albers P; Heinrich Heine University, Medical Faculty, Dusseldorf, Germany., Buonerba C; University Federico II, Naples, Italy., Di Lorenzo G; University Federico II, Naples, Italy., Vaishampayan UN; Wayne State University Cancer Center, Detroit, MI., North SA; Cross Cancer Institute, Edmonton, AB, Canada., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Hussain SA; University of Liverpool, Liverpool, United Kingdom., Pal S; City of Hope Cancer Center, Duarte, CA., Eigl BJ; British Columbia Cancer Agency, Vancouver, BC, Canada. Electronic address: Bernie.Eigl@bccancer.bc.ca.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2016 Aug; Vol. 14 (4), pp. 331-40. Date of Electronic Publication: 2015 Oct 24.
Autor:
Sonpavde G; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA., Pond GR, Fougeray R, Choueiri TK, Qu AQ, Vaughn DJ, Niegisch G, Albers P, James ND, Wong YN, Ko YJ, Sridhar SS, Galsky MD, Petrylak DP, Vaishampayan UN, Khan A, Vogelzang NJ, Beer TM, Stadler WM, O'Donnell PH, Sternberg CN, Rosenberg JE, Bellmunt J
Publikováno v:
European urology [Eur Urol] 2013 Apr; Vol. 63 (4), pp. 717-23. Date of Electronic Publication: 2012 Nov 26.
Autor:
Vaishampayan UN; Division of Hematology/Oncology, Department of Medicine, Wayne State University Medical Center, Detroit, Michigan 48201, USA. vaishamu@karmanos.org, Faulkner JR, Small EJ, Redman BG, Keiser WL, Petrylak DP, Crawford ED
Publikováno v:
Cancer [Cancer] 2005 Oct 15; Vol. 104 (8), pp. 1627-32.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Agarwal, Neeraj, Pal, Sumanta K., Hahn, Andrew W., Nussenzveig, Roberto H., Pond, Gregory R., Gupta, Sumati V., Wang, Jue, Bilen, Mehmet A., Naik, Gurudatta, Ghatalia, Pooja, Hoimes, Christopher J., Gopalakrishnan, Dharmesh, Barata, Pedro C., Drakaki, Alexandra, Faltas, Bishoy M., Kiedrowski, Lesli A., Lanman, Richard B., Nagy, Rebecca J., Vogelzang, Nicholas J., Boucher, Kenneth M., Vaishampayan, Ulka N., Sonpavde, Guru, Grivas, Petros
Biomarker-guided clinical trials are increasingly common in metastatic urothelial carcinoma (mUC), yet patients for whom contemporary tumor tissue is not available are not eligible. Technological advancements in sequencing have made cell-free circula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::06a32c04939ea939177434afe55a5741
https://europepmc.org/articles/PMC6857169/
https://europepmc.org/articles/PMC6857169/